Page 128 - ICD AR21 EN

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021
(CONTINUED)
30 RISK MANAGEMENT (Continued)
iii) Exposure Amounts and ECL coverage
The Corporation recognizes 12-month ECL for stage 1 instruments and lifetime ECL for stage 2 instruments. For stage 3 instruments, it calculates a loss allowance amount based on the difference between the carrying amount of the instrument and the net present value of expected future cash flows discounted at the instrument’s original effective profit rate (EPR) where applicable.
Tables below present the breakdown of gross exposure amount and ECL by mode of finance, for financial instruments measured at amortized cost as at 31 December 2021 and 2020.
An analysis of changes in the financial assets before ECL allowance and the corresponding ECL allowance is as follows:
31 December 2021
Description
Stage 1 USD
Stage 2 USD
Stage 3 USD
Total USD
Gross carrying amount before ECL:
Cash and cash equivalents
Commodity Murabaha and Wakala placements Sukuk investments
Murabaha financing
Installment sales financing Ijarah Muntahia Bittamleek Istisna’a assets
Other assets
ECL:
Cash and cash equivalents
Commodity Murabaha and Wakala placements Sukuk investments
Murabaha financing
Installment sales financing
Ijarah Muntahia Bittamleek
Istisna’a assets
Other assets
158,647,462 - 188,710,810 - - - 99,103,386 9,223,490
207,445,113 93,085,179 175,806,789 26,058,218 - 17,475,758 9,625,081 -
655 - 11,601 - - - 2,971,561 292,960 4,918,328 6,726,775 246,491 588,982 - 1,629,527 - -
- 28,207,149 10,585,098 61,086,570
29,776,277 53,812,487 - 4,083,273
- 14,066,639 10,585,098 45,718,021 11,088,261 34,166,491 - 2,701,219
158,647,462 216,917,959 10,585,098 169,413,446
330,306,569 255,677,494 17,475,758 13,708,354
655 14,078,240 10,585,098 48,982,542 22,733,364 35,001,964 1,629,527 2,701,219
839,338,641
145,842,645
187,550,854
1,172,732,140
31 December 2021
Description
Stage 1 USD
Stage 2 USD
Stage 3 USD
Total USD
8,148,636
9,238,244
118,325,729
135,712,609
126 ICD ANNUAL REPORT 2021